ABSTRACT The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with MMR II. We divided 80 subjects into two groups, comparing MMR titers to recent COVID-19 severity levels.


Read more…


Citation: Jeffrey E. GoldWilliam H. BaumgartlRamazan A. OkyayWarren E. LichtPaul L. Fidel Jr.Mairi C. NoverrLarry P. TilleyDavid J. HurleyBalázs RadaJohn W. Ashford